BioImagene, Inc. has partnered with LigoLab for the development of an interface involving it’s Virtuoso and an anatomic pathology module of laboratory information system (LIS) by LigoLab. Virtuoso is a digital pathology workflow software. The interface will provide shared access to critical information and functionality from both systems to labs, optimizing the clinical workflow.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
LigoLab is engaged in the provision of solutions to simplify cutting edge technology in the laboratory. It’s LIS Suite is a laboratory information system that is dynamic, comprehensive, and scalable. The suite also accommodates a variety of laboratory environments, specifically Anatomical Pathology workflow.
BioImagene (http://www.bioimagene.com) is the leading provider of innovative and scalable digital pathology solutions for clinical diagnostics. The company's total digital pathology solution is comprised of the Virtuoso™ digital pathology application software, iScan™ family of automated digital slide scanners, and a rich menu of Companion Algorithms™. BioImagene’s innovative product line includes a unique image viewing input device called the iSlide™, and a high-performance pathology workstation called Crescendo™. BioImagene is also the platinum sponsor of PathXchange™, a vendor neutral, not for profit website for the pathology community. BioImagene’s products are FDA-cleared for specific clinical applications and are intended for research use for other applications.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
